• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左炔诺孕酮宫内节育系统在有效避孕中的作用。

Role of the levonorgestrel intrauterine system in effective contraception.

作者信息

Attia Abdelhamid M, Ibrahim Magdy M, Abou-Setta Ahmed M

机构信息

Department of Obstetrics and Gynecology, Cairo University, Cairo, Egypt.

出版信息

Patient Prefer Adherence. 2013 Aug 9;7:777-85. doi: 10.2147/PPA.S36948. eCollection 2013.

DOI:10.2147/PPA.S36948
PMID:23990713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3749061/
Abstract

Norgestrel, a synthetic progestin chemically derived from 19-nortestosterone, is six times more potent than progesterone, with variable binding affinity to various steroid receptors. The levonorgestrel-releasing intrauterine system (LNG IUS) provides a long-acting, highly effective, and reversible form of contraception, with a pearl index of 0.18 per 100 women-years. The locally released hormone leads to endometrial concentrations that are 200-800 times those found after daily oral use and a plasma level that is lower than that with other forms of levonorgestrel-containing contraception. The contraceptive effect of the LNG IUS is achieved mainly through its local suppressive effect on the endometrium, leading to endometrial thinning, glandular atrophy, and stromal decidualization without affecting ovulation. The LNG IUS is generally well tolerated. The main side effects are related to its androgenic activity, which is usually mild and transient, resolving after the first few months. Menstrual abnormalities are also common but well tolerated, and even become desirable (eg, amenorrhea, hypomenorrhea, and oligomenorrhea) with proper counseling of the patient during the choice of the method of contraception. The satisfaction rates after 3 years of insertion are high, reaching between 77% and 94%. The local effect of the LNG IUS on the endometrium and low rates of systemic adverse effects have led to its use in other conditions rather than contraception, as for the treatment of endometrial hyperplasia, benign menorrhagia, endometriosis, adenomyosis, and uterine fibroids.

摘要

炔诺孕酮是一种化学合成的孕激素,由19-去甲睾酮衍生而来,其效力是孕酮的6倍,对各种甾体受体具有可变的结合亲和力。左炔诺孕酮宫内节育系统(LNG IUS)提供了一种长效、高效且可逆的避孕方式,每100名妇女年的妊娠率为0.18。局部释放的激素导致子宫内膜浓度是每日口服后浓度的200 - 800倍,血浆水平低于其他含左炔诺孕酮的避孕方式。LNG IUS的避孕效果主要通过其对子宫内膜的局部抑制作用实现,导致子宫内膜变薄、腺体萎缩和间质蜕膜化,而不影响排卵。LNG IUS通常耐受性良好。主要副作用与其雄激素活性有关,通常较轻且短暂,在最初几个月后会消失。月经异常也很常见,但耐受性良好,甚至在选择避孕方法时对患者进行适当咨询后会变得令人满意(如闭经、月经过少和稀发月经)。放置3年后的满意度很高,达到77%至94%。LNG IUS对子宫内膜的局部作用和较低的全身不良反应发生率使其被用于避孕以外的其他情况,如治疗子宫内膜增生、良性月经过多、子宫内膜异位症、子宫腺肌病和子宫肌瘤。

相似文献

1
Role of the levonorgestrel intrauterine system in effective contraception.左炔诺孕酮宫内节育系统在有效避孕中的作用。
Patient Prefer Adherence. 2013 Aug 9;7:777-85. doi: 10.2147/PPA.S36948. eCollection 2013.
2
Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.使用左炔诺孕酮宫内节育系统的女性子宫内膜中的孕激素受体亚型和前列腺素脱氢酶
Hum Reprod. 1998 May;13(5):1210-7. doi: 10.1093/humrep/13.5.1210.
3
A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.左炔诺孕酮宫内节育系统的风险效益评估。
Drug Saf. 1996 Dec;15(6):430-40. doi: 10.2165/00002018-199615060-00006.
4
Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.长期宫内左炔诺孕酮给药后子宫内膜蜕膜化的形态学和功能特征
Hum Reprod. 1998 May;13(5):1218-24. doi: 10.1093/humrep/13.5.1218.
5
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.用于治疗月经过多的孕激素或释放孕激素的宫内节育系统。
Cochrane Database Syst Rev. 2015 Apr 30(4):CD002126. doi: 10.1002/14651858.CD002126.pub3.
6
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.用于治疗月经过多的孕激素或释放孕激素的宫内节育系统。
Cochrane Database Syst Rev. 2005 Oct 19(4):CD002126. doi: 10.1002/14651858.CD002126.pub2.
7
Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.左炔诺孕酮宫内节育器作为一种具有治疗特性的避孕方法。
Contraception. 1995 Nov;52(5):269-76. doi: 10.1016/0010-7824(95)00210-2.
8
The ultrastructure of human endometrium is altered by administration of intrauterine levonorgestrel.宫内给予左炔诺孕酮会改变人子宫内膜的超微结构。
Hum Reprod. 1998 Jul;13(7):1846-53. doi: 10.1093/humrep/13.7.1846.
9
Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.使用左炔诺孕酮宫内节育系统对严重增大的子宫腺肌病子宫进行药物治疗。
Contraception. 1999 Sep;60(3):173-5. doi: 10.1016/s0010-7824(99)00075-x.
10
Hormonal intrauterine devices.激素宫内节育器
Ann Med. 1993 Apr;25(2):143-7. doi: 10.3109/07853899309164158.

引用本文的文献

1
Long-acting intrauterine systems: Recent advances, current challenges, and future opportunities.长效宫内节育系统:最新进展、当前挑战与未来机遇。
Adv Drug Deliv Rev. 2022 Dec;191:114581. doi: 10.1016/j.addr.2022.114581. Epub 2022 Oct 19.
2
Application of Modeling and Simulation to Identify a Shortened Study Duration and Novel Bioequivalence Metric for a Long-Acting Intrauterine System.应用建模与仿真缩短长效宫内节育系统研究周期并建立新的生物等效性度量方法
AAPS J. 2022 May 2;24(3):63. doi: 10.1208/s12248-022-00715-z.
3
Depressive Disorder With Panic Attacks After Replacement of an Intrauterine Device Containing Levonorgestrel: A Case Report.左炔诺孕酮宫内节育器取出后伴惊恐发作的抑郁障碍:一例报告
Front Psychiatry. 2020 Aug 28;11:561685. doi: 10.3389/fpsyt.2020.561685. eCollection 2020.
4
Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives.经前烦躁障碍(PMDD)女性的避孕咨询:当前观点
Open Access J Contracept. 2019 Sep 20;10:27-39. doi: 10.2147/OAJC.S183193. eCollection 2019.
5
Norethindrone is superior to combined oral contraceptive pills in short-term delay of menses and onset of breakthrough bleeding: a randomized trial.去氧孕烯优于复方口服避孕药短期延迟月经和突破性出血的发生:一项随机试验。
BMC Womens Health. 2019 May 28;19(1):70. doi: 10.1186/s12905-019-0766-6.
6
Use of the Levonorgestrel Intrauterine Device in Women With Type 2 Diabetes.左炔诺孕酮宫内节育器在2型糖尿病女性中的应用。
Clin Diabetes. 2018 Jul;36(3):251-256. doi: 10.2337/cd17-0028.

本文引用的文献

1
Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial.米索前列醇在未生育妇女中放置宫内节育器前的应用:一项随机临床试验。
Hum Reprod. 2013 Aug;28(8):2118-25. doi: 10.1093/humrep/det240. Epub 2013 Jun 5.
2
Levonorgestrel-releasing intrauterine system for atypical endometrial hyperplasia.左炔诺孕酮宫内缓释系统治疗非典型子宫内膜增生
Cochrane Database Syst Rev. 2013 Jun 5(6):CD009458. doi: 10.1002/14651858.CD009458.pub2.
3
The efficacy of intrauterine versus oral progestin for the treatment of endometrial hyperplasia. A prospective randomized comparative study.宫腔内应用孕激素与口服孕激素治疗子宫内膜增生的疗效:一项前瞻性随机对照研究。
Clin Exp Obstet Gynecol. 2013;40(1):122-6.
4
LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trial.LNG-IUS 治疗围绝经期非典型子宫内膜增生:一项随机对照试验。
J Gynecol Oncol. 2013 Apr;24(2):128-34. doi: 10.3802/jgo.2013.24.2.128. Epub 2013 Apr 5.
5
Prophylactic use of levonorgestrel-releasing intrauterine system in women with breast cancer treated with tamoxifen: a randomized controlled trial.左炔诺孕酮宫内缓释系统在接受他莫昔芬治疗的乳腺癌妇女中的预防性应用:一项随机对照试验。
Obstet Gynecol. 2013 May;121(5):943-950. doi: 10.1097/AOG.0b013e31828bf80c.
6
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids.用于子宫肌瘤的孕激素或释放孕激素的宫内节育系统。
Cochrane Database Syst Rev. 2013 Feb 28(2):CD008994. doi: 10.1002/14651858.CD008994.pub2.
7
Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.手术后用于有症状子宫内膜异位症的左炔诺孕酮宫内节育器(LNG-IUD)
Cochrane Database Syst Rev. 2013 Jan 31(1):CD005072. doi: 10.1002/14651858.CD005072.pub3.
8
The effect of nitroprusside on IUD insertion experience in nulliparous women: a pilot study.硝苯地平对初产妇放置宫内节育器体验的影响:一项初步研究。
Contraception. 2013 Apr;87(4):421-5. doi: 10.1016/j.contraception.2012.10.030. Epub 2012 Dec 4.
9
Efficacy of levonorgestrel-releasing intrauterine system versus oral progestins in treatment of simple endometrial hyperplasia without atypia.左炔诺孕酮宫内缓释系统与口服孕激素治疗单纯非典型子宫内膜增生的疗效比较。
Reprod Sci. 2013 Jan;20(1):45-50. doi: 10.1177/1933719112459243.
10
Neisseria gonorrhea and Chlamydia trachomatis screening at intrauterine device insertion and pelvic inflammatory disease.淋病奈瑟菌和沙眼衣原体筛查在宫内节育器放置和盆腔炎中。
Obstet Gynecol. 2012 Dec;120(6):1314-21. doi: 10.1097/aog.0b013e318273364c.